Consolidated statement of changes in equity
| |
Equity attributable to owners of the parent |
|
|
| (in € millions) |
Share capital |
Share premium |
Treasury shares |
Consolidated reserves |
Net income |
Currency translation reserves |
Amounts recognised directly in equity |
Total attributable to owners of the parent |
Non-controlling interests |
Total |
| Balance at 31/12/2022 |
1,473 |
12,719 |
(2,088) |
9,872 |
4,259 |
(240) |
(56) |
25,939 |
3,470 |
29,409 |
| Net income for the period |
- |
- |
- |
- |
4,702 |
- |
- |
4,702 |
400 |
5,102 |
| Other comprehensive income recognised directly in the equity of controlled companies |
- |
- |
- |
- |
- |
154 |
(281) |
(127) |
164 |
37 |
| Other comprehensive income recognised directly in the equity of companies accounted for under the equity method |
- |
- |
- |
- |
- |
(1) |
(47) |
(49) |
- |
(49) |
| Total comprehensive income for the period |
- |
- |
- |
- |
4,702 |
152 |
(328) |
4,526 |
564 |
5,090 |
| Increase in share capital |
21 |
688 |
- |
- |
- |
- |
- |
709 |
3 |
712 |
| Decrease in share capital |
(22) |
- |
835 |
(813) |
- |
- |
- |
- |
(5) |
(5) |
| Transactions in treasury shares |
- |
- |
(166) |
(231) |
- |
- |
- |
(397) |
- |
(397) |
| Appropriation of net income and dividend payments |
- |
- |
- |
1,966 |
(4,259) |
- |
- |
(2,293) |
(187) |
(2,481) |
| Share-based payments (IFRS 2) |
- |
- |
- |
265 |
- |
- |
- |
265 |
- |
265 |
| Impact of acquisitions or disposals of non-controlling interests after acquisition of control |
- |
- |
- |
1 |
- |
- |
- |
1 |
2 |
3 |
| Changes in consolidation scope |
- |
- |
- |
10 |
- |
(4) |
2 |
8 |
(10) |
(1) |
| Other |
- |
- |
- |
(648) |
- |
1 |
1 |
(647) |
91 |
(556) |
| Balance at 31/12/2023 |
1,473 |
13,407 |
(1,419) |
10 422 |
4,702 |
(91) |
(382) |
28,113 |
3,928 |
32,040 |
| Net income for the period |
- |
- |
- |
- |
4,863 |
- |
- |
4,863 |
410 |
5,274 |
| Other comprehensive income recognised directly in the equity of controlled companies |
- |
- |
- |
- |
- |
31 |
(118) |
(87) |
(154) |
(241) |
| Other comprehensive income recognised directly in the equity of companies accounted for under the equity method |
- |
- |
- |
- |
- |
18 |
(28) |
(9) |
- |
(9) |
| Total comprehensive income for the period |
- |
- |
- |
- |
4,863 |
49 |
(146) |
4,767 |
256 |
5,024 |
| Increase in share capital |
16 |
652 |
- |
- |
- |
- |
- |
668 |
2 |
670 |
| Decrease in share capital |
(35) |
- |
1,495 |
(1,460) |
- |
- |
- |
- |
(3) |
(3) |
| Transactions in treasury shares |
- |
- |
(1,642) |
(270) |
- |
- |
- |
(1,912) |
- |
(1,912) |
| Appropriation of net income and dividend payments |
- |
- |
- |
2,133 |
(4,702) |
- |
- |
(2,570) |
(902) |
(3,472) |
| Share-based payments (IFRS 2) |
- |
- |
- |
344 |
- |
- |
- |
344 |
- |
344 |
| Impact of acquisitions or disposals of non-controlling interests after acquisition of control |
- |
- |
- |
1 |
- |
1 |
- |
2 |
- |
2 |
|
Changes in consolidation scope (*)
|
- |
- |
- |
25 |
- |
7 |
(32) |
- |
804 |
804 |
| Other |
- |
- |
- |
530 |
- |
1 |
4 |
535 |
1 |
536 |
| Balance at 31/12/2024 |
1,455 |
14,059 |
(1,566) |
11,724 |
4,863 |
(32) |
(555) |
29,947 |
4,085 |
34,032 |